BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 22122743)

  • 1. Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans?
    Zhang M; Chen M; Tong W
    Chem Res Toxicol; 2012 Jan; 25(1):122-9. PubMed ID: 22122743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
    Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
    J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats.
    Hanafusa H; Morikawa Y; Uehara T; Kaneto M; Ono A; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2014 Oct; 324():43-54. PubMed ID: 25051504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A performance evaluation of three drug-induced liver injury biomarkers in the rat: alpha-glutathione S-transferase, arginase 1, and 4-hydroxyphenyl-pyruvate dioxygenase.
    Bailey WJ; Holder D; Patel H; Devlin P; Gonzalez RJ; Hamilton V; Muniappa N; Hamlin DM; Thomas CE; Sistare FD; Glaab WE
    Toxicol Sci; 2012 Dec; 130(2):229-44. PubMed ID: 22872058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systems toxicology used in nanotoxicology: mechanistic insights into the hepatotoxicity of nano-copper particles from toxicogenomics.
    Yang B; Wang Q; Lei R; Wu C; Shi C; Wang Q; Yuan Y; Wang Y; Luo Y; Hu Z; Ma H; Liao M
    J Nanosci Nanotechnol; 2010 Dec; 10(12):8527-37. PubMed ID: 21121362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans.
    Uehara T; Kiyosawa N; Shimizu T; Omura K; Hirode M; Imazawa T; Mizukawa Y; Ono A; Miyagishima T; Nagao T; Urushidani T
    Hum Exp Toxicol; 2008 Jan; 27(1):23-35. PubMed ID: 18480146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury.
    Ozer JS; Chetty R; Kenna G; Palandra J; Zhang Y; Lanevschi A; Koppiker N; Souberbielle BE; Ramaiah SK
    Regul Toxicol Pharmacol; 2010 Apr; 56(3):237-46. PubMed ID: 19903504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling in rat liver treated with various hepatotoxic-compounds inducing coagulopathy.
    Hirode M; Omura K; Kiyosawa N; Uehara T; Shimuzu T; Ono A; Miyagishima T; Nagao T; Ohno Y; Urushidani T
    J Toxicol Sci; 2009 Jun; 34(3):281-93. PubMed ID: 19483382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a cell-based assay system considering drug metabolism and immune- and inflammatory-related factors for the risk assessment of drug-induced liver injury.
    Yano A; Oda S; Fukami T; Nakajima M; Yokoi T
    Toxicol Lett; 2014 Jul; 228(1):13-24. PubMed ID: 24747151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating mitochondrial biomarkers for drug-induced liver injury.
    Shi Q; Yang X; Mattes WB; Mendrick DL; Harrill AH; Beger RD
    Biomark Med; 2015; 9(11):1215-23. PubMed ID: 26507261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced hepatotoxicity test using gamma-glutamylcysteine synthetase knockdown rat.
    Morita M; Akai S; Hosomi H; Tsuneyama K; Nakajima M; Yokoi T
    Toxicol Lett; 2009 Sep; 189(2):159-65. PubMed ID: 19481141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA; Yang Y; Waring JF
    Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward predictive models for drug-induced liver injury in humans: are we there yet?
    Chen M; Bisgin H; Tong L; Hong H; Fang H; Borlak J; Tong W
    Biomark Med; 2014; 8(2):201-13. PubMed ID: 24521015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat.
    Thulin P; Hornby RJ; Auli M; Nordahl G; Antoine DJ; Starkey Lewis P; Goldring CE; Park BK; Prats N; Glinghammar B; Schuppe-Koistinen I
    Biomarkers; 2017 Jul; 22(5):461-469. PubMed ID: 27978773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predose and Postdose Blood Gene Expression Profiles Identify the Individuals Susceptible to Acetaminophen-Induced Liver Injury in Rats.
    Lu X; Hu B; Zheng J; Ji C; Fan X; Gao Y
    PLoS One; 2015; 10(10):e0141750. PubMed ID: 26512990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced liver injury: recent advances in diagnosis and risk assessment.
    Kullak-Ublick GA; Andrade RJ; Merz M; End P; Benesic A; Gerbes AL; Aithal GP
    Gut; 2017 Jun; 66(6):1154-1164. PubMed ID: 28341748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor antagonist NP260.
    Harrill AH; Eaddy JS; Rose K; Cullen JM; Ramanathan L; Wanaski S; Collins S; Ho Y; Watkins PB; Lecluyse EL
    Toxicol Appl Pharmacol; 2014 Jun; 277(2):131-7. PubMed ID: 24699182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.